No abstract available
Keywords:
COVID- 19; Cancer; FITC; Immunotherapy; SARS-CoV-2 vaccines; mRNA-based vaccine.
Publication types
-
Letter
-
Practice Guideline
MeSH terms
-
2019-nCoV Vaccine mRNA-1273
-
Antineoplastic Agents, Immunological / therapeutic use*
-
BNT162 Vaccine
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines / therapeutic use*
-
ChAdOx1 nCoV-19
-
France
-
Humans
-
Immune Checkpoint Inhibitors / therapeutic use*
-
Immunotherapy, Adoptive*
-
Neoplasms / drug therapy*
-
Receptors, Chimeric Antigen
-
SARS-CoV-2
Substances
-
Antineoplastic Agents, Immunological
-
COVID-19 Vaccines
-
Immune Checkpoint Inhibitors
-
Receptors, Chimeric Antigen
-
ChAdOx1 nCoV-19
-
2019-nCoV Vaccine mRNA-1273
-
BNT162 Vaccine